Mylan Introduces Educational Website About Generic Drugs, www.ChoosingGenerics.com

Mar 23, 2011, 07:00 ET from Mylan Inc.

PITTSBURGH, March 23, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration has always had the same rigorous quality standards for generic medications that it has for branded drugs, yet questions about generics persist. To help consumers better understand the true value, reliability and high quality of generics, Mylan Inc. (Nasdaq: MYL) today announced the launch of an educational website about generics drugs, www.ChoosingGenerics.com.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/mylan/48586/

(Logo: http://photos.prnewswire.com/prnh/20110323/MM47107LOGO )

Mylan President Heather Bresch said, “While the debate over health care reform continues, one of the only proven solutions for controlling the rise of health care costs is generic pharmaceuticals. Generic drug companies have been providing high quality, FDA-approved affordable alternatives to expensive branded medications in the U.S. for more than 25 years. ChoosingGenerics.com will help to equip consumers with accurate and easy-to-understand information about generic pharmaceuticals. We believe the website will be increasingly important as more and more brand name drugs become available in generic form. Our goals for the site are for visitors to learn the truth about generics, choose affordable medicine and take action by speaking with their health care professional about generic drugs if they have additional questions.”

Learn, Choose, Act

ChoosingGenerics.com calls on people to Learn, Choose and Act:

Helpful Resources Available on ChoosingGenerics.com

Available on www.ChoosingGenerics.com are printer-friendly resources, including:

The website will be regularly updated with new and relevant information and resources about generic drugs.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

SOURCE Mylan Inc.



RELATED LINKS

http://www.mylan.com